GlassScriptPhysician profile
Pramod Kakarala
NPI 1972881795
$5,143.27
in general payments reported to CMS, 2019-2025
16 companies · $23.96 in 2025
The $23.96 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,557 · 2020: $400 · 2021: $1,882 · 2022: $578 · 2023: $679 · 2024: $22.74 · 2025: $23.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,839.38 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $494.20 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $467.37 | 2019-2023 | Lokelma |
| Pfizer INC. | $244.95 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $227.30 | 2021-2023 | Soliris |
| Gilead Sciences, INC. | $145.50 | 2023 | Veklury |
| Gt Medical Technologies, INC | $140.00 | 2023 | Gammatile |
| Novartis Pharmaceuticals Corporation | $139.45 | 2019-2022 | |
| Glaxosmithkline, LLC. | $120.81 | 2021 | |
| Janssen Scientific Affairs, LLC | $102.10 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.98 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.16 | 2019-2021 | |
| Abbott Laboratories | $22.88 | 2023 | Freestyle Libre |
| Boston Scientific Corporation | $18.48 | 2020 | |
| La Jolla Pharmaceutical Company | $16.84 | 2023 | Xerava |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramod Kakarala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.